CALIGAN PARTNERS LP

PrivateCIK: 1727492
Location

NEW YORK, NY

πŸ“‹ What this filing means

CALIGAN PARTNERS LP filed this quarterly 13F‑HR report disclosing 17 equity positions with a total reported market value of $520.17M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.

17
Positions
$520.17M
Total AUM (reported)
38.37M
Total Shares

Allocation by class

TOTAL AUM$520.17M17 positions
COM$258.38M49.7%
SPONSORED ADS$148.71M28.6%
COM NEW$113.08M21.7%

Portfolio Concentration

Top 358.5%4–1034.5%11–257.0%TOP 1093.0%0%100%
Top 3$304.31M58.5%
4–10$179.68M34.5%
11–25$36.18M7.0%

Top 3 weight

58.5%

Top 10 weight

93.0%

Voting Authority Distribution

Total shares with voting rights: 38.37M

Sole

Full voting authority

38.37M

shares

% of voting shares100.0%
Shared

Joint voting authority

0.00

shares

% of voting shares0.0%
None

No voting authority

0.00

shares

% of voting shares0.0%

Investment Discretion (by position count)

Sole17
Shared0
Other0
Dominant voting typeSole Β· 100.0% of voting shares
Institutional Holdings17
Rows:

VERONA PHARMA PLC

SOLE
SPONSORED ADS
Shares1.44M
TypeSH
Market value$135.90M
26.13%
Sole
1.44M
Shared
0.00
None
0.00

LIQUIDIA CORPORATION

SOLE
COM NEW
Shares8.12M
TypeSH
Market value$101.16M
19.45%
Sole
8.12M
Shared
0.00
None
0.00

EXELIXIS INC

SOLE
COM
Shares1.53M
TypeSH
Market value$67.25M
12.93%
Sole
1.53M
Shared
0.00
None
0.00

AGIOS PHARMACEUTICALS INC

SOLE
COM
Shares1.07M
TypeSH
Market value$35.63M
6.85%
Sole
1.07M
Shared
0.00
None
0.00

MERUS N V

SOLE
COM
Shares657K
TypeSH
Market value$34.56M
6.64%
Sole
657K
Shared
0.00
None
0.00

EVOLUS INC

SOLE
COM
Shares3.34M
TypeSH
Market value$30.78M
5.92%
Sole
3.34M
Shared
0.00
None
0.00

MINERALYS THERAPEUTICS INC

SOLE
COM
Shares2.02M
TypeSH
Market value$27.29M
5.25%
Sole
2.02M
Shared
0.00
None
0.00

REVOLUTION MEDICINES INC

SOLE
COM
Shares636.84K
TypeSH
Market value$23.43M
4.50%
Sole
636.84K
Shared
0.00
None
0.00

ANIKA THERAPEUTICS INC

SOLE
COM
Shares1.44M
TypeSH
Market value$15.18M
2.92%
Sole
1.44M
Shared
0.00
None
0.00

ABIVAX SA

SOLE
SPONSORED ADS
Shares1.67M
TypeSH
Market value$12.81M
2.46%
Sole
1.67M
Shared
0.00
None
0.00

Y-MABS THERAPEUTICS INC

SOLE
COM
Shares2.34M
TypeSH
Market value$10.57M
2.03%
Sole
2.34M
Shared
0.00
None
0.00

REZOLUTE INC

SOLE
COM NEW
Shares1.54M
TypeSH
Market value$6.88M
1.32%
Sole
1.54M
Shared
0.00
None
0.00

BIOCRYST PHARMACEUTICALS INC

SOLE
COM
Shares638.91K
TypeSH
Market value$5.72M
1.10%
Sole
638.91K
Shared
0.00
None
0.00

SELLAS LIFE SCIENCES GROUP I

SOLE
COM NEW
Shares2.30M
TypeSH
Market value$5.04M
0.97%
Sole
2.30M
Shared
0.00
None
0.00

VERRICA PHARMACEUTICALS INC

SOLE
COM
Shares9.24M
TypeSH
Market value$4.90M
0.94%
Sole
9.24M
Shared
0.00
None
0.00

TYRA BIOSCIENCES INC

SOLE
COM
Shares189.95K
TypeSH
Market value$1.82M
0.35%
Sole
189.95K
Shared
0.00
None
0.00

AURA BIOSCIENCES INC

SOLE
COM
Shares200K
TypeSH
Market value$1.25M
0.24%
Sole
200K
Shared
0.00
None
0.00
CALIGAN PARTNERS LP 13F Holdings β€” 17 Positions | Finecho